Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive
Year: 2013
Type: review
Source: Endocrine Reviews
DOI: 10.1210/er.2012-1033
Institutions: Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases, Feinstein Institute for Medical Research, Albert Einstein College of Medicine, Yeshiva University, VA NY Harbor Healthcare System, NYU Langone Health, New York University, Hofstra University, Geisinger Health System, Stony Brook University Hospital, Rambam Health Care Campus, Icahn School of Medicine at Mount Sinai, University of Catania, Ospedale Garibaldi, University of Mississippi Medical Center, University of Mississippi
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: insulin-like growth factor II, non-islet cell tumor hypoglycemia, IGF-II receptor, IGF binding proteins, insulin-like growth factor I, insulin receptor, IGF-1 receptor, insulinoma, acromegaly, hepatocellular carcinoma, fibroma, fibrosarcoma, history of insulin discovery, tyrosine kinase signaling, cancer surgery
Open Access status: closed
OpenAlex ID: W2111432896
